Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sara, Piccinelli"'
Autor:
Antonio Piralla, Davide Mileto, Alberto Rizzo, Guglielmo Ferrari, Federica Giardina, Stefano Gaiarsa, Greta Petazzoni, Micol Bianchi, Federica Salari, Fiorenza Bracchitta, Josè Camilla Sammartino, Alessandro Ferrari, Gloria Gagliardi, Alessandro Mancon, Claudio Fenizia, Mara Biasin, Francesca Rovida, Stefania Paolucci, Elena Percivalle, Alessandra Lombardi, Valeria Micheli, Silvia Nozza, Antonella Castagna, Davide Moschese, Spinello Antinori, Andrea Gori, Paolo Bonfanti, Roberto Rossotti, Antonella D'Arminio Monforte, Federica Attanasi, Marcello Tirani, Danilo Cereda, Fausto Baldanti, Maria Rita Gismondo, Miriam Cutrera, Marianna Cuomo, Federica De Poli, Giulia Campanini, Antonino Maria Guglielmo Pitrolo, Elizabeth Iskandar, Irene Cassaniti, Raffaele Bruno, Giuliano Rizzardini, Massimo Puoti, Francesco Castelli, Laura Corsico, Andrea Giacomelli, Giacomo Pozza, Giacomo Casalini, Angelo Raccagni, Bendetta Trentacapilli, Costanza Bertoni, Elena Bruzzesi, Caterina Candela, Daniele Tesoro, Giovanni Mule, Alessandra Bandera, Antonio Muscatello Bianca Mariani, Manuel Maffeo, Riccardo Vecchio, Sara Piccinelli
Publikováno v:
Travel Medicine and Infectious Disease, Vol 59, Iss , Pp 102698- (2024)
Background: Mpox virus (MPXV) has recently spread outside of sub-Saharan Africa. This large multicentre study was conducted in Lombardy, the most densely populated Italian region accounting for more than 40% of Italian cases. The present study aims t
Externí odkaz:
https://doaj.org/article/3f1b0a37603c408895b47779b1b11b32
Autor:
Andreia Maia, Mubin Tarannum, Joana R. Lérias, Sara Piccinelli, Luis Miguel Borrego, Markus Maeurer, Rizwan Romee, Mireia Castillo-Martin
Publikováno v:
Cells, Vol 13, Iss 5, p 451 (2024)
Natural killer (NK) cells have gained attention as a promising adoptive cell therapy platform for their potential to improve cancer treatments. NK cells offer distinct advantages over T-cells, including major histocompatibility complex class I (MHC-I
Externí odkaz:
https://doaj.org/article/0e62f82e51834b4986099cbf9c5395be
Publikováno v:
Seminars in Hematology. 60:42-51
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Since their discovery CD4+FOXP3+ regulatory T cells (Tregs) represented a promising tool to induce tolerance in allogeneic hematopoietic cell transplantation. Preclinical models proved that adoptive transfer of Tregs or the use of compounds that can
Externí odkaz:
https://doaj.org/article/d0fcd2a967dc4a3381cce28975b1f1aa
Autor:
Riccardo Vecchio, Roberta Lattanzio, Chiara Marrocu, Sudwaric Sharma, Giovanni Cicconi, Sara Piccinelli, Gaia Ferraguzzi, Anna Odone, Catia Borriello, Danilo Cereda
Publikováno v:
Population Medicine. 5
Autor:
Silvia Deandrea, Chiara Marrocu, Sudwaric Sharma, Roberta Lattanzio, Giovanni Cicconi, Sara Piccinelli, Danilo Cereda, Catia Borriello, Silvana Castaldi, Riccardo Vecchio, Gaia Ferraguzzi
Publikováno v:
Population Medicine. 5
Autor:
Danilo Cereda, Sara Piccinelli, Riccardo vecchio, Giovanni Cicconi, Roberta Lattanzio, Gaia Ferraguzzi, Chiara Marrocu, Silvana Castaldi, Sudwaric Sharma, Anna Odone, Catia Borriello
Publikováno v:
Population Medicine. 5
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
FoxP3+ regulatory T cells (Tregs) are a subset of CD4+ T cells that can suppress proliferation and effector functions of T cells, B cells, NK cells, and antigen-presenting cells. Treg deficiency causes dramatic immunologic disease in both animal mode
Externí odkaz:
https://doaj.org/article/d32550cda2ef4597a9a1c5c81f53e5e0
Autor:
Alessandra Carotti, Brunangelo Falini, Massimo F. Martelli, Sara Piccinelli, C. Zucchetti, Loredana Ruggeri, Adelmo Terenzi, Simonetta Saldi, Antonio Pierini, Mauro Di Ianni, Sara Tricarico, Cynthia Aristei, Roberta Iacucci Ostini, Maria Paola Martelli, Olivia Minelli, Mara Merluzzi, Samanta Bonato, Franca Falzetti, Cristina Mecucci, Gianluca Ingrosso, Tiziana Zei, Andrea Velardi, Antonella Mancusi, Sara Ciardelli, Rita Tognellini, Roberto Limongello
Publikováno v:
Blood Adv
Allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective treatment in eradicating high-risk acute myeloid leukemia (AML). Here, we present data from a novel HLA-haploidentical HSCT protocol that addressed the 2 remaining major
Autor:
Castaldi, Maurizio Lecce, Giacomo Biganzoli, Luca Agnello, Ignazio Belisario, Giovanni Cicconi, Marilena D’Amico, Francesca De Giorgi, Angelo Ferilli, Gaia Ferraguzzi, Fabio Guzzardi, Danilo Lanzillotti, Roberta Lattanzio, Chiara Marrocu, Maria Emanuela Noto, Sara Piccinelli, Noemi Sabatelli, Sheila Santisteban, Sudwaric Sharma, Livia Tognaccini, Silvana
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 11; Pages: 6500
Background: Healthcare workers (HCWs) are a historical key target of influenza vaccination programs. For the 2021–2022 season, WHO considered the coadministration of a flu and a COVID-19 vaccine as acceptable and recommended it to allow for higher